Consuming “raw, natural medical cannabis flower” is associated with “significant improvements” in insomnia patients, finds a new study published by the open access journal Medicines.
For the study 409 people with a specified condition of insomnia completed 1056 medical cannabis administration sessions using the Releaf AppTM educational software during which they recorded real-time ratings of “self-perceived insomnia severity levels prior to and following consumption, experienced side effects, and product characteristics, including combustion method, cannabis subtypes, and/or major cannabinoid contents of cannabis consumed.” Within-user effects of different flower characteristics were modeled using “a fixed effects panel regression approach with standard errors clustered at the user level.”
Researchers found that “Releaf AppTM users showed an average symptom severity reduction of -4.5 points on a 0⁻10 point visual analogue scale.” Use of pipes and vaporizers was associated with “greater symptom relief and more positive and context-specific side effects as compared to the use of joints, while vaporization was also associated with lower negative effects.” Cannabidiol (CBD) “was associated with greater statistically significant symptom relief than tetrahydrocannabinol (THC), but the cannabinoid levels generally were not associated with differential side effects.”
The study concludes; “Consumption of medical Cannabis flower is associated with significant improvements in perceived insomnia with differential effectiveness and side effect profiles, depending on the product characteristics.”
For the full study, click here.